Johnson & Johnson Innovation - JJDC’s Zymergen Inc. Common Stock ZY Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$662K	Buy	+16,553	New	+$653K	0.07%	16

Other funds holding ZY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's ZY Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC opened a new position in Zymergen Inc. Common Stock (ZY) in Q2 2021: 16,553 shares worth $662K. The stake represents 0.07% of the portfolio and ranks #16 among its holdings.

81 funds tracked by Wall St. Rank hold ZY as of Q2 2021.

Johnson & Johnson Innovation - JJDC held 16,553 shares of Zymergen Inc. Common Stock worth $662K as of Q2 2021.
Zymergen Inc. Common Stock was a new Johnson & Johnson Innovation - JJDC position in Q2 2021.
Zymergen Inc. Common Stock made up 0.07% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #16 holding.
81 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.